Tissue analysis - A powerful tool for drug discovery and development

Bioanalysis

Volumn 4, Issue 21, 2012, Pages 2545-2547

  Ho, Stacy ^a  

^a Drug Metabolism and Pharmacokinetics   (United States)

Author keywords

compliance; high throughput; regulatory; technology; tissue

Indexed keywords

DRUG;

ANALYTIC METHOD; BIOASSAY; CELL LEVEL; DATA ANALYSIS; DRUG ACCUMULATION; DRUG BRAIN LEVEL; DRUG CONTROL; DRUG DETERMINATION; DRUG DISTRIBUTION; DRUG EXPOSURE; DRUG FORMULATION; DRUG LIVER LEVEL; DRUG MECHANISM; DRUG METABOLISM; DRUG QUALITY; DRUG TISSUE LEVEL; ENZYME ASSAY; FEEDBACK SYSTEM; HIGH THROUGHPUT SCREENING; KIDNEY INJURY; LEGAL ASPECT; LIQUID LIQUID EXTRACTION; LIVER TOXICITY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION SPECTROMETRY; PATIENT COMPLIANCE; PROCESS DEVELOPMENT; PROCESS TECHNOLOGY; QUALITY CONTROL; RADIOACTIVITY; RADIOIMMUNOASSAY; REVIEW; STANDARD; TARGET CELL; TISSUE ANALYSIS; TISSUE HOMOGENATE; TISSUE SECTION;

CHEMISTRY TECHNIQUES, ANALYTICAL; DRUG DISCOVERY; HIGH-THROUGHPUT SCREENING ASSAYS; ORGAN SPECIFICITY; PHARMACEUTICAL PREPARATIONS; SPECIMEN HANDLING;

EID: 84870200924     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.12.240     Document Type: Review

References (6)

1. Christensen J, Wase AW. Distribution of S35 in the Mouse after Administration of S3510-(dimethylaminopropyl)-2-chlorophenothiazine (chlorpromazine). Acta Pharmacologica et Toxicologica 12(1), 81-84 (1956).
2. Dietrich LS, Kaplan LA, Friedland IM, Martin DS. Quantitative biochemical differences between tumor and host tissue. VI. 6-Aminonicotinamide antagonism of DPN-dependent enzymatic systems. Cancer Res. 18(11), 1272-1280 (1958).
3. Castellino S, Groseclose MR, Wagner D. MALDI imaging mass spectrometry: bridging biology and chemistry in drug development. Bioanalysis 3(21), 2427-2441 (2011).
4. Kertesz V, Van Berkel GJ. Fully automated liquid extraction-based surface sampling and ionization using a chip-based robotic nanoelectrospray platform. J. Mass Spect. 45(3), 252-260 (2010).
5. Booth B. When do you need a validated assay? Bioanalysis 3(24), 2729-2730 (2011).
6. Lee J, Devanarayan V, Barrett Y et al. Fit-for-purpose method development and validation for successful biomarker measurement. Pharm. Res. 23(2), 312-328 (2006). (Pubitemid 43237862)